OralDNA Labs Acquires Sensible Diagnostics for Rapid POC Molecular Testing
OralDNA Labs acquired Sensible Diagnostics to enhance its rapid point-of-care molecular diagnostic testing capabilities.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Molecular Diagnostics, Swabs |
OralDNA Labs acquired Sensible Diagnostics to enhance its rapid point-of-care molecular diagnostic testing capabilities.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Allergy & Autoimmune |
Augurex Life Sciences and ARUP Labs collaborated on a test to detect rheumatoid arthritis for improved early diagnostic capabilities.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Cardiovascular, Molecular Diagnostics |
AMPEL BioSolutions’ new CardioGENE blood test predicts heart disease by identifying genetic markers and inflammatory pathways.
Read MorePosted by Andy Lundin | Oct 17, 2024 | Respiratory Disease |
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Read MorePosted by Chris Wolski | Oct 10, 2024 | Sequencing Systems |
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read More